Showing 241 - 260 results of 4,913 for search '"Hodgkin's lymphoma"', query time: 0.26s Refine Results
  1. 241
  2. 242
  3. 243
  4. 244

    Role of brentuximab vedotin in the treatment of relapsed or refractory Hodgkin lymphoma by Siddiqi T, Thomas SH, Chen R

    Published 2014-02-01
    “…Keywords: Hodgkin lymphoma, brentuximab vedotin, CD 30, antibody-drug conjugate…”
    Get full text
    Article
  5. 245

    Non-Hodgkins lymphoma of the nasal cavity: A case report by Konnor Kennedy, MSc, Cory Tremblay, MSc, Euan Zhang, MD, Gordon Tsang, MD, Ruba Kiwan, MD

    Published 2023-11-01
    “…The mass was subsequently diagnosed as diffuse large B-cell non-Hodgkin lymphoma (NHL). Nasal/paranasal space involvement in NHL is uncommon, representing only 0.2%-2% of cases. …”
    Get full text
    Article
  6. 246

    Molecular Characterisation of Epstein–Barr Virus in Classical Hodgkin Lymphoma by Valerija Begić, Petra Korać, Slavko Gašparov, Marija Rozman, Petra Simicic, Snjezana Zidovec-Lepej

    Published 2022-12-01
    “…Hodgkin lymphomas (HLs) are a heterogeneous group of lymphoid neoplasia associated with Epstein–Barr virus (EBV) infection. …”
    Get full text
    Article
  7. 247
  8. 248
  9. 249
  10. 250
  11. 251
  12. 252
  13. 253

    PET-adapted approaches to primary therapy for advanced Hodgkin lymphoma by Noemie Lang, Michael Crump

    Published 2020-06-01
    “…Recent results of randomized phase III studies of FDG-PET-adapted therapy for advanced Hodgkin lymphoma (HL) have clearly demonstrated benefit to alteration of treatment according to interim response, in particular regarding reducing toxicity while maintaining efficacy. …”
    Get full text
    Article
  14. 254

    Outcome of first relapse of Hodgkin lymphoma: Single Institution experience by Najma Shaheen, Ata Ur Rehman Maaz, Muhammad Saghir Khan

    Published 2020-11-01
    “… Objectives: 1:To determine outcome of first relapse of Hodgkin Lymphoma with standard dose chemotherapy. 2: To identify the prognostic factors predicting survival outcome in pediatric relapsed Hodgkin lymphoma. …”
    Get full text
    Article
  15. 255
  16. 256
  17. 257
  18. 258

    Advances and Clinical Outcomes in Hodgkin Lymphoma in the Era of Novel Therapies by Annalisa Paviglianiti, Nicolò Rampi

    Published 2023-03-01
    “…Hodgkin lymphoma (HL) is traditionally considered one of the hematological malignancies with the highest rate of cure, ranging from 70 to 90% depending on the disease and patient features [...]…”
    Get full text
    Article
  19. 259
  20. 260

    Primary testicular non-Hodgkin's lymphoma: a review article by Komal Bhatia, Ashok Kumar Vaid, Sachin Gupta, Dinesh Chandra Doval, Vineet Talwar

    “…Primary testicular non-Hodgkin's lymphoma was first described as a clinical entity in 1866. …”
    Get full text
    Article